Sciegen Pharmaceuticals Inc recalls

8 recalls on record · latest: February 17, 2023

Official U.S. recall history for Sciegen Pharmaceuticals Inc, compiled from official government records.

Get recall alerts

Free email alert whenever Sciegen Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.

Sciegen Pharmaceuticals Inc recalls Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppaug…

February 17, 2023 · Drug & medication recalls Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gaba…

ScieGen Pharmaceuticals, Inc recalls WP Westminster, more — Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms

May 3, 2019 · Drug & medication recalls Due to detection of NDEA (N-Nitrosodiethylamine) Impurity — Potential Lack of S…

Westminister Irbesartan Tablets recalled over manufacturing violations

October 29, 2018 · Drug & medication recalls Moderate risk CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-ni…

GSMS Irbesartan Tablets recalled over manufacturing violations

October 29, 2018 · Drug & medication recalls Moderate risk CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-ni…

Westminister Irbesartan Tablets recalled over manufacturing violations

October 29, 2018 · Drug & medication recalls Moderate risk CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-ni…

GSMS Irbesartan Tablets recalled over manufacturing violations

October 29, 2018 · Drug & medication recalls Moderate risk CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-ni…

GSMS Irbesartan Tablets recalled over manufacturing violations

October 29, 2018 · Drug & medication recalls Moderate risk CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-ni…

Westminister Irbesartan Tablets recalled over manufacturing violations

October 29, 2018 · Drug & medication recalls Moderate risk CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-ni…